APO Research
Talk to an analyst

APO RESEARCH · REPORT

Montelukast Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Montelukast Drug Industry Research Report 2026

20 December 2025146 pages

Choose your research edition.

Industry ResearchMontelukast Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast Drug Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Montelukast Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast Drug Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast Drug Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Montelukast Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Montelukast Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Montelukast Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Montelukast Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Montelukast Drug include Teva, Sandoz, Merck & Co., Mylan, Unimark, Unichem Laboratories, Torrent Pharmaceuticals, Shanghai Anbison Lab and Perrigo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Montelukast Drug market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Montelukast Drug Market by Company

Teva

Sandoz

Merck & Co.

Mylan

Unimark

Unichem Laboratories

Torrent Pharmaceuticals

Shanghai Anbison Lab

Perrigo

MACLEODS

Lannett Company

Jubilant Pharma

Hikma Group

Hetero

Glenmark Pharmaceuticals

Dr. Reddys Laboratories

CSPC Ouyi Pharmaceutical

Cipla

Aurobindo Pharma

Apotex

Amneal Pharmaceuticals

Ajanta Pharma

Accord Healthcare

Montelukast Drug Segment by Type

Tablets

Oral Granules

Montelukast Drug Segment by Application

Hospital

Drug Store

Others

Montelukast Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Montelukast Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Montelukast Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Montelukast Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Montelukast Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Montelukast Drug Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Montelukast Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Montelukast Drug Revenue of Manufacturers (2021-2026) Table 9. Global Montelukast Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Montelukast Drug Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Montelukast Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Montelukast Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Montelukast Drug, Product Type & Application Table 14. Global Montelukast Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Montelukast Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Company Information Table 19. Teva Business Overview Table 20. Teva Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Teva Montelukast Drug Product Portfolio Table 22. Teva Recent Developments Table 23. Sandoz Company Information Table 24. Sandoz Business Overview Table 25. Sandoz Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sandoz Montelukast Drug Product Portfolio Table 27. Sandoz Recent Developments Table 28. Merck & Co. Company Information Table 29. Merck & Co. Business Overview Table 30. Merck & Co. Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Merck & Co. Montelukast Drug Product Portfolio Table 32. Merck & Co. Recent Developments Table 33. Mylan Company Information Table 34. Mylan Business Overview Table 35. Mylan Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Mylan Montelukast Drug Product Portfolio Table 37. Mylan Recent Developments Table 38. Unimark Company Information Table 39. Unimark Business Overview Table 40. Unimark Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Unimark Montelukast Drug Product Portfolio Table 42. Unimark Recent Developments Table 43. Unichem Laboratories Company Information Table 44. Unichem Laboratories Business Overview Table 45. Unichem Laboratories Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Unichem Laboratories Montelukast Drug Product Portfolio Table 47. Unichem Laboratories Recent Developments Table 48. Torrent Pharmaceuticals Company Information Table 49. Torrent Pharmaceuticals Business Overview Table 50. Torrent Pharmaceuticals Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Torrent Pharmaceuticals Montelukast Drug Product Portfolio Table 52. Torrent Pharmaceuticals Recent Developments Table 53. Shanghai Anbison Lab Company Information Table 54. Shanghai Anbison Lab Business Overview Table 55. Shanghai Anbison Lab Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Shanghai Anbison Lab Montelukast Drug Product Portfolio Table 57. Shanghai Anbison Lab Recent Developments Table 58. Perrigo Company Information Table 59. Perrigo Business Overview Table 60. Perrigo Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Perrigo Montelukast Drug Product Portfolio Table 62. Perrigo Recent Developments Table 63. MACLEODS Company Information Table 64. MACLEODS Business Overview Table 65. MACLEODS Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. MACLEODS Montelukast Drug Product Portfolio Table 67. MACLEODS Recent Developments Table 68. Lannett Company Company Information Table 69. Lannett Company Business Overview Table 70. Lannett Company Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Lannett Company Montelukast Drug Product Portfolio Table 72. Lannett Company Recent Developments Table 73. Jubilant Pharma Company Information Table 74. Jubilant Pharma Business Overview Table 75. Jubilant Pharma Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Jubilant Pharma Montelukast Drug Product Portfolio Table 77. Jubilant Pharma Recent Developments Table 78. Hikma Group Company Information Table 79. Hikma Group Business Overview Table 80. Hikma Group Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hikma Group Montelukast Drug Product Portfolio Table 82. Hikma Group Recent Developments Table 83. Hetero Company Information Table 84. Hetero Business Overview Table 85. Hetero Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hetero Montelukast Drug Product Portfolio Table 87. Hetero Recent Developments Table 88. Glenmark Pharmaceuticals Company Information Table 89. Glenmark Pharmaceuticals Business Overview Table 90. Glenmark Pharmaceuticals Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Glenmark Pharmaceuticals Montelukast Drug Product Portfolio Table 92. Glenmark Pharmaceuticals Recent Developments Table 93. Dr. Reddys Laboratories Company Information Table 94. Dr. Reddys Laboratories Business Overview Table 95. Dr. Reddys Laboratories Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Dr. Reddys Laboratories Montelukast Drug Product Portfolio Table 97. Dr. Reddys Laboratories Recent Developments Table 98. CSPC Ouyi Pharmaceutical Company Information Table 99. CSPC Ouyi Pharmaceutical Business Overview Table 100. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolio Table 102. CSPC Ouyi Pharmaceutical Recent Developments Table 103. Cipla Company Information Table 104. Cipla Business Overview Table 105. Cipla Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Cipla Montelukast Drug Product Portfolio Table 107. Cipla Recent Developments Table 108. Aurobindo Pharma Company Information Table 109. Aurobindo Pharma Business Overview Table 110. Aurobindo Pharma Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Aurobindo Pharma Montelukast Drug Product Portfolio Table 112. Aurobindo Pharma Recent Developments Table 113. Apotex Company Information Table 114. Apotex Business Overview Table 115. Apotex Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Apotex Montelukast Drug Product Portfolio Table 117. Apotex Recent Developments Table 118. Amneal Pharmaceuticals Company Information Table 119. Amneal Pharmaceuticals Business Overview Table 120. Amneal Pharmaceuticals Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Amneal Pharmaceuticals Montelukast Drug Product Portfolio Table 122. Amneal Pharmaceuticals Recent Developments Table 123. Ajanta Pharma Company Information Table 124. Ajanta Pharma Business Overview Table 125. Ajanta Pharma Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Ajanta Pharma Montelukast Drug Product Portfolio Table 127. Ajanta Pharma Recent Developments Table 128. Accord Healthcare Company Information Table 129. Accord Healthcare Business Overview Table 130. Accord Healthcare Montelukast Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Accord Healthcare Montelukast Drug Product Portfolio Table 132. Accord Healthcare Recent Developments Table 133. Global Montelukast Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Montelukast Drug Sales by Region (2021-2026) & (W Units) Table 135. Global Montelukast Drug Sales Market Share by Region (2021-2026) Table 136. Global Montelukast Drug Sales by Region (2027-2032) & (W Units) Table 137. Global Montelukast Drug Sales Market Share by Region (2027-2032) Table 138. Global Montelukast Drug Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Montelukast Drug Revenue Market Share by Region (2021-2026) Table 140. Global Montelukast Drug Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Montelukast Drug Revenue Market Share by Region (2027-2032) Table 142. North America Montelukast Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 144. North America Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 145. North America Montelukast Drug Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Montelukast Drug Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Montelukast Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 149. Europe Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 150. Europe Montelukast Drug Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Montelukast Drug Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Montelukast Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 154. Asia Pacific Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 155. Asia Pacific Montelukast Drug Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Montelukast Drug Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Montelukast Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 159. South America Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 160. South America Montelukast Drug Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Montelukast Drug Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Montelukast Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Montelukast Drug Sales by Country (2021-2026) & (W Units) Table 164. Middle East and Africa Montelukast Drug Sales by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Montelukast Drug Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Montelukast Drug Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Montelukast Drug Sales by Type (2021-2026) & (W Units) Table 168. Global Montelukast Drug Sales by Type (2027-2032) & (W Units) Table 169. Global Montelukast Drug Sales Market Share by Type (2021-2026) Table 170. Global Montelukast Drug Sales Market Share by Type (2027-2032) Table 171. Global Montelukast Drug Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Montelukast Drug Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Montelukast Drug Revenue Market Share by Type (2021-2026) Table 174. Global Montelukast Drug Revenue Market Share by Type (2027-2032) Table 175. Global Montelukast Drug Price by Type (2021-2026) & (US$/Unit) Table 176. Global Montelukast Drug Price by Type (2027-2032) & (US$/Unit) Table 177. Global Montelukast Drug Sales by Application (2021-2026) & (W Units) Table 178. Global Montelukast Drug Sales by Application (2027-2032) & (W Units) Table 179. Global Montelukast Drug Sales Market Share by Application (2021-2026) Table 180. Global Montelukast Drug Sales Market Share by Application (2027-2032) Table 181. Global Montelukast Drug Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Montelukast Drug Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Montelukast Drug Revenue Market Share by Application (2021-2026) Table 184. Global Montelukast Drug Revenue Market Share by Application (2027-2032) Table 185. Global Montelukast Drug Price by Application (2021-2026) & (US$/Unit) Table 186. Global Montelukast Drug Price by Application (2027-2032) & (US$/Unit) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Montelukast Drug Distributors List Table 190. Montelukast Drug Customers List Table 191. Montelukast Drug Industry Trends Table 192. Montelukast Drug Industry Drivers Table 193. Montelukast Drug Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Montelukast Drug Product Image Figure 5. Global Montelukast Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Montelukast Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Montelukast Drug Sales (2021-2032) & (W Units) Figure 8. Global Montelukast Drug Average Price (US$/Unit) & (2021-2032) Figure 9. Tablets Product Image Figure 10. Oral Granules Product Image Figure 11. Hospital Product Image Figure 12. Drug Store Product Image Figure 13. Others Product Image Figure 14. Global Montelukast Drug Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Montelukast Drug, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Montelukast Drug Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Montelukast Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Montelukast Drug Sales by Region in 2025 Figure 20. Global Montelukast Drug Revenue by Region in 2025 Figure 21. North America Montelukast Drug Market Size by Country in 2025 Figure 22. North America Montelukast Drug Sales Market Share by Country (2021-2032) Figure 23. North America Montelukast Drug Revenue Market Share by Country (2021-2032) Figure 24. United States Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Montelukast Drug Market Size by Country in 2025 Figure 27. Europe Montelukast Drug Sales Market Share by Country (2021-2032) Figure 28. Europe Montelukast Drug Revenue Market Share by Country (2021-2032) Figure 29. Germany Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific Montelukast Drug Market Size by Country in 2025 Figure 35. Asia Pacific Montelukast Drug Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific Montelukast Drug Revenue Market Share by Country (2021-2032) Figure 37. China Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America Montelukast Drug Market Size by Country in 2025 Figure 46. South America Montelukast Drug Sales Market Share by Country (2021-2032) Figure 47. South America Montelukast Drug Revenue Market Share by Country (2021-2032) Figure 48. Mexico Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Montelukast Drug Market Size by Country in 2025 Figure 52. Middle East and Africa Montelukast Drug Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Montelukast Drug Revenue Market Share by Country (2021-2032) Figure 54. Turkey Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Montelukast Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Montelukast Drug Sales Market Share by Type (2021-2032) Figure 58. Global Montelukast Drug Revenue Market Share by Type (2021-2032) Figure 59. Global Montelukast Drug Price (US$/Unit) by Type (2021-2032) Figure 60. Global Montelukast Drug Sales Market Share by Application (2021-2032) Figure 61. Global Montelukast Drug Revenue Market Share by Application (2021-2032) Figure 62. Global Montelukast Drug Price (US$/Unit) by Application (2021-2032) Figure 63. Montelukast Drug Value Chain Figure 64. Montelukast Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Montelukast Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Tablets
  • Oral Granules
Applications
  • Hospital
  • Drug Store
  • Others
Companies covered
  • Teva
  • Sandoz
  • Merck & Co.
  • Mylan
  • Unimark
  • Unichem Laboratories
  • Torrent Pharmaceuticals
  • Shanghai Anbison Lab
  • Perrigo
  • MACLEODS
  • Lannett Company
  • Jubilant Pharma
  • Hikma Group
  • Hetero
  • Glenmark Pharmaceuticals
  • Dr. Reddys Laboratories
  • CSPC Ouyi Pharmaceutical
  • Cipla
  • Aurobindo Pharma
  • Apotex
  • Amneal Pharmaceuticals
  • Ajanta Pharma
  • Accord Healthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Montelukast Drug Market Size (2021-2032)
  4. 2.2.2 Global Montelukast Drug Sales (2021-2032)
  5. 2.2.3 Global Montelukast Drug Market Average Price (2021-2032)
  6. 2.3 Montelukast Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Tablets
  9. 2.3.3 Oral Granules
  10. 2.4 Montelukast Drug by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Drug Store
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Montelukast Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Montelukast Drug Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Montelukast Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Montelukast Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Montelukast Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Montelukast Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Montelukast Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Montelukast Drug, Established Date
  9. 3.9 Global Montelukast Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva
  2. 4.1.1 Teva Company Information
  3. 4.1.2 Teva Business Overview
  4. 4.1.3 Teva Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Montelukast Drug Product Portfolio
  6. 4.1.5 Teva Recent Developments
  7. 4.2 Sandoz
  8. 4.2.1 Sandoz Company Information
  9. 4.2.2 Sandoz Business Overview
  10. 4.2.3 Sandoz Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sandoz Montelukast Drug Product Portfolio
  12. 4.2.5 Sandoz Recent Developments
  13. 4.3 Merck & Co.
  14. 4.3.1 Merck & Co. Company Information
  15. 4.3.2 Merck & Co. Business Overview
  16. 4.3.3 Merck & Co. Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck & Co. Montelukast Drug Product Portfolio
  18. 4.3.5 Merck & Co. Recent Developments
  19. 4.4 Mylan
  20. 4.4.1 Mylan Company Information
  21. 4.4.2 Mylan Business Overview
  22. 4.4.3 Mylan Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Mylan Montelukast Drug Product Portfolio
  24. 4.4.5 Mylan Recent Developments
  25. 4.5 Unimark
  26. 4.5.1 Unimark Company Information
  27. 4.5.2 Unimark Business Overview
  28. 4.5.3 Unimark Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Unimark Montelukast Drug Product Portfolio
  30. 4.5.5 Unimark Recent Developments
  31. 4.6 Unichem Laboratories
  32. 4.6.1 Unichem Laboratories Company Information
  33. 4.6.2 Unichem Laboratories Business Overview
  34. 4.6.3 Unichem Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Unichem Laboratories Montelukast Drug Product Portfolio
  36. 4.6.5 Unichem Laboratories Recent Developments
  37. 4.7 Torrent Pharmaceuticals
  38. 4.7.1 Torrent Pharmaceuticals Company Information
  39. 4.7.2 Torrent Pharmaceuticals Business Overview
  40. 4.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Torrent Pharmaceuticals Montelukast Drug Product Portfolio
  42. 4.7.5 Torrent Pharmaceuticals Recent Developments
  43. 4.8 Shanghai Anbison Lab
  44. 4.8.1 Shanghai Anbison Lab Company Information
  45. 4.8.2 Shanghai Anbison Lab Business Overview
  46. 4.8.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Shanghai Anbison Lab Montelukast Drug Product Portfolio
  48. 4.8.5 Shanghai Anbison Lab Recent Developments
  49. 4.9 Perrigo
  50. 4.9.1 Perrigo Company Information
  51. 4.9.2 Perrigo Business Overview
  52. 4.9.3 Perrigo Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Perrigo Montelukast Drug Product Portfolio
  54. 4.9.5 Perrigo Recent Developments
  55. 4.10 MACLEODS
  56. 4.10.1 MACLEODS Company Information
  57. 4.10.2 MACLEODS Business Overview
  58. 4.10.3 MACLEODS Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 MACLEODS Montelukast Drug Product Portfolio
  60. 4.10.5 MACLEODS Recent Developments
  61. 4.11 Lannett Company
  62. 4.11.1 Lannett Company Company Information
  63. 4.11.2 Lannett Company Business Overview
  64. 4.11.3 Lannett Company Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Lannett Company Montelukast Drug Product Portfolio
  66. 4.11.5 Lannett Company Recent Developments
  67. 4.12 Jubilant Pharma
  68. 4.12.1 Jubilant Pharma Company Information
  69. 4.12.2 Jubilant Pharma Business Overview
  70. 4.12.3 Jubilant Pharma Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Jubilant Pharma Montelukast Drug Product Portfolio
  72. 4.12.5 Jubilant Pharma Recent Developments
  73. 4.13 Hikma Group
  74. 4.13.1 Hikma Group Company Information
  75. 4.13.2 Hikma Group Business Overview
  76. 4.13.3 Hikma Group Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hikma Group Montelukast Drug Product Portfolio
  78. 4.13.5 Hikma Group Recent Developments
  79. 4.14 Hetero
  80. 4.14.1 Hetero Company Information
  81. 4.14.2 Hetero Business Overview
  82. 4.14.3 Hetero Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hetero Montelukast Drug Product Portfolio
  84. 4.14.5 Hetero Recent Developments
  85. 4.15 Glenmark Pharmaceuticals
  86. 4.15.1 Glenmark Pharmaceuticals Company Information
  87. 4.15.2 Glenmark Pharmaceuticals Business Overview
  88. 4.15.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Glenmark Pharmaceuticals Montelukast Drug Product Portfolio
  90. 4.15.5 Glenmark Pharmaceuticals Recent Developments
  91. 4.16 Dr. Reddys Laboratories
  92. 4.16.1 Dr. Reddys Laboratories Company Information
  93. 4.16.2 Dr. Reddys Laboratories Business Overview
  94. 4.16.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Dr. Reddys Laboratories Montelukast Drug Product Portfolio
  96. 4.16.5 Dr. Reddys Laboratories Recent Developments
  97. 4.17 CSPC Ouyi Pharmaceutical
  98. 4.17.1 CSPC Ouyi Pharmaceutical Company Information
  99. 4.17.2 CSPC Ouyi Pharmaceutical Business Overview
  100. 4.17.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolio
  102. 4.17.5 CSPC Ouyi Pharmaceutical Recent Developments
  103. 4.18 Cipla
  104. 4.18.1 Cipla Company Information
  105. 4.18.2 Cipla Business Overview
  106. 4.18.3 Cipla Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Cipla Montelukast Drug Product Portfolio
  108. 4.18.5 Cipla Recent Developments
  109. 4.19 Aurobindo Pharma
  110. 4.19.1 Aurobindo Pharma Company Information
  111. 4.19.2 Aurobindo Pharma Business Overview
  112. 4.19.3 Aurobindo Pharma Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Aurobindo Pharma Montelukast Drug Product Portfolio
  114. 4.19.5 Aurobindo Pharma Recent Developments
  115. 4.20 Apotex
  116. 4.20.1 Apotex Company Information
  117. 4.20.2 Apotex Business Overview
  118. 4.20.3 Apotex Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Apotex Montelukast Drug Product Portfolio
  120. 4.20.5 Apotex Recent Developments
  121. 4.21 Amneal Pharmaceuticals
  122. 4.21.1 Amneal Pharmaceuticals Company Information
  123. 4.21.2 Amneal Pharmaceuticals Business Overview
  124. 4.21.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Amneal Pharmaceuticals Montelukast Drug Product Portfolio
  126. 4.21.5 Amneal Pharmaceuticals Recent Developments
  127. 4.22 Ajanta Pharma
  128. 4.22.1 Ajanta Pharma Company Information
  129. 4.22.2 Ajanta Pharma Business Overview
  130. 4.22.3 Ajanta Pharma Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Ajanta Pharma Montelukast Drug Product Portfolio
  132. 4.22.5 Ajanta Pharma Recent Developments
  133. 4.23 Accord Healthcare
  134. 4.23.1 Accord Healthcare Company Information
  135. 4.23.2 Accord Healthcare Business Overview
  136. 4.23.3 Accord Healthcare Montelukast Drug Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Accord Healthcare Montelukast Drug Product Portfolio
  138. 4.23.5 Accord Healthcare Recent Developments
5 Global Montelukast Drug Market Scenario by Region
  1. 5.1 Global Montelukast Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Montelukast Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Montelukast Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Montelukast Drug Sales by Region: 2027-2032
  5. 5.3 Global Montelukast Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Montelukast Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Montelukast Drug Revenue by Region: 2027-2032
  8. 5.4 North America Montelukast Drug Market Facts & Figures by Country
  9. 5.4.1 North America Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Montelukast Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Montelukast Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Montelukast Drug Market Facts & Figures by Country
  15. 5.5.1 Europe Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Montelukast Drug Sales by Country (2021-2032)
  17. 5.5.3 Europe Montelukast Drug Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Montelukast Drug Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Montelukast Drug Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Montelukast Drug Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Montelukast Drug Market Facts & Figures by Country
  35. 5.7.1 South America Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Montelukast Drug Sales by Country (2021-2032)
  37. 5.7.3 South America Montelukast Drug Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Montelukast Drug Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Montelukast Drug Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Montelukast Drug Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Montelukast Drug Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Montelukast Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Montelukast Drug Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Montelukast Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Montelukast Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Montelukast Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Montelukast Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Montelukast Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Montelukast Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Montelukast Drug Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Montelukast Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Montelukast Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Montelukast Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Montelukast Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Montelukast Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Montelukast Drug Value Chain Analysis
  2. 8.1.1 Montelukast Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Montelukast Drug Production Mode & Process
  5. 8.2 Montelukast Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Montelukast Drug Distributors
  8. 8.2.3 Montelukast Drug Customers
9 Global Montelukast Drug Analyzing Market Dynamics
  1. 9.1 Montelukast Drug Industry Trends
  2. 9.2 Montelukast Drug Industry Drivers
  3. 9.3 Montelukast Drug Industry Opportunities and Challenges
  4. 9.4 Montelukast Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst